Clazakizumab - CISMeF

Preferred Label : Clazakizumab;

NCIt synonyms : Anti-Interleukin 6 Monoclonal Antibody ALD518;

NCIt definition : A humanized monoclonal antibody directed against the pro-inflammatory cytokine interleukin-6 (Il-6) with potential immunomodulating activity. Upon administration, clazakizumab binds to and blocks the activity of IL-6, which may mitigate the catabolic effects of IL-6.;

UNII : 4S38Z8RA9O;

CAS number : 1236278-28-6; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1236278-28-6 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : ALD518; BMS-945429;

NCI Metathesaurus CUI : CL408638;

Details

Origin ID

C82359;

UMLS CUI

C4077748;

Currated CISMeF NLP mapping
- clazakizumab [MeSH Supplementary Concept]
- clazakizumab [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- clazakizumab [MeSH Supplementary Concept]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]
has_target
- Interleukin-6 [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients